Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English
News18 » Business
2-min read

China's New Drug Law May Open Door for Indian Generic Medicines, Says Report

India has been demanding that China open its pharmaceutical market to Indian drugs as part of the efforts to lower the $57 billion trade deficit in about $95.5 billion total trade last year.

PTI

Updated:August 27, 2019, 10:18 PM IST
facebookTwitterskypewhatsapp
China's New Drug Law May Open Door for Indian Generic Medicines, Says Report
Representative image. (Photo courtesy: AFP)
Loading...

Beijing: China's revised drug law, which removes drugs that are legal in foreign countries but not approved in China from the category of fake medicines, may allow entry of Indian generic medicines in the country, media reports said on Tuesday.

China's top legislature, the Standing Committee of National People's Congress, passed the revised law on Monday to enhance management and supervision of the pharmaceutical market following numerous fake drugs and vaccine cases that had triggered a call for stronger measures to ensure drug safety.

India has been demanding that China open its pharmaceutical market to Indian drugs as part of the efforts to lower the $57 billion trade deficit in about $95.5 billion total trade last year.

No major Indian pharma company managed to establish itself in China in view of the rigid regulations and the costs involved.

Legal foreign drugs, including generic drugs from India, will not be treated as fake medicine in China based on a revised drug administration law that will take effect on December 1, state-run

Global Times reported.

The latest revision removes drugs that are legal in foreign countries but not approved in China from the category of fake medicines.

It also states that people who take these drugs without official approval into China can be granted leniency if the amount of the drug is small.

They will be exempt from punishment if the drug does not cause health problems or delays anyone's treatment, thepaper.cn reported.

Some experts take the move as a sign that China is opening its market to cheap generic medicines, especially from India, which caused national concern in 2018 following the release of the

Chinese black comedy 'Dying to Survive'.

The revised clause addresses patients' needs, Liu Changqiu, a health law expert and research fellow at the Shanghai Academy of Social Sciences, told the Global Times.

Different countries may apply different standards to drugs, but patients should be allowed the right to buy legal foreign drugs as long as they are effective, Liu said.

However, Liu said the revision did not mean that China was ready to relax management on imported generic medicine.

People who want to import generic drugs for profit still have to follow Chinese laws to register and get approval in advance.

Most generic medicines which applied for registration in China from 2016 to 2018 were reportedly produced in India and Switzerland.

Experts warned legal risks still exist for distributors who buy drugs abroad, the report said.

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

Read full article
Loading...
Next Story
Next Story

Also Watch

facebookTwitterskypewhatsapp
Most Active
Company Price Change %Gain
HDFC 2,049.30 3.78
Maruti Suzuki 6,591.95 10.39
ICICI Bank 417.50 7.99
HDFC Bank 1,199.60 8.95
Reliance 1,254.35 6.39
Company Price Change %Gain
Astral Poly Tec 1,213.70 5.25
HDFC 2,052.10 3.92
SBI Life Insura 815.85 1.73
Zee Entertain 301.10 -2.49
Maruti Suzuki 6,585.25 10.89
Top Gainers
Company Price Change %Gain
Eicher Motors 17,860.20 13.38
Hero Motocorp 2,862.90 13.06
IndusInd Bank 1,419.60 10.71
UltraTechCement 4,269.65 10.43
Maruti Suzuki 6,591.95 10.39
Company Price Change %Gain
Hero Motocorp 2,866.50 13.19
Maruti Suzuki 6,585.25 10.89
IndusInd Bank 1,419.60 10.74
Bajaj Finance 3,705.60 10.19
SBI 301.70 10.09
Top Losers
Company Price Change %Gain
Power Grid Corp 196.20 -2.46
Zee Entertain 301.40 -2.41
Infosys 805.00 -1.91
TCS 2,065.45 -1.74
NTPC 119.85 -1.52
Company Price Change %Gain
Power Grid Corp 196.35 -2.39
Infosys 805.10 -1.94
TCS 2,065.60 -1.74
NTPC 119.90 -1.52

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results